On 30 November 2024, Roche Bangladesh Limited organized a Policy Dialogue titled, “Identifying Cancer (Lymphoma) Management Gaps in Bangladesh”. By bringing together government officials, healthcare authorities, specialists, and industry experts, this discussion aimed to push for tangible steps towards improving cancer care in Bangladesh, ensuring that patients with diffuse large B-cell lymphoma (DLBCL) have better treatment options and better chances at survival.